{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:21Z","timestamp":1791928941227,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471329"],"award-info":[{"award-number":["81471329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1000707"],"award-info":[{"award-number":["2016YFC1000707"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.seizure.2022.03.003","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T13:37:37Z","timestamp":1646746657000},"page":"23-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Sirolimus treatment for tuberous sclerosis complex prior to epilepsy: Evidence from a registry-based real-world study"],"prefix":"10.1016","volume":"97","author":[{"given":"Yan-Wen","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Dun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2022.03.003_bib0001","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2022.03.003_bib0002","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.03.003_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: findings from the TOSCA Study","volume":"4","author":"Nabbout","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2022.03.003_bib0004","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1111\/epi.14529","article-title":"Everolimus in infants with tuberous sclerosis complex\u2013related West syndrome: first results from a single-center prospective observational study","volume":"59","author":"Samueli","year":"2018","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2022.03.003_bib0005","first-page":"812","article-title":"Efficacy and safety of rapamycin in treatment of children with epilepsy complicated with tuberous sclerosis","volume":"52","author":"Zou","year":"2014","journal-title":"Chin J Pediatr"},{"key":"10.1016\/j.seizure.2022.03.003_bib0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13023-019-1077-6","article-title":"Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age\u2013a multicenter retrospective study","volume":"14","author":"Saffari","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.seizure.2022.03.003_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2020.03.018","article-title":"Sirolimus improves seizure control in pediatric patients with tuberous sclerosis: a prospective cohort study","volume":"79","author":"He","year":"2020","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.seizure.2022.03.003_bib0008","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"Jozwiak","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2022.03.003_bib0009","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.25956","article-title":"Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial","volume":"89","author":"Kotulska","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2022.03.003_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Annals Neurol"},{"key":"10.1016\/j.seizure.2022.03.003_bib0011","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10072-014-1842-1","article-title":"The mTOR signaling pathway and neuronal stem\/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model","volume":"35","author":"Russo","year":"2014","journal-title":"Neurolog Sci"},{"key":"10.1016\/j.seizure.2022.03.003_bib0012","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2022.03.003_bib0013","doi-asserted-by":"crossref","first-page":"e35885","DOI":"10.1371\/journal.pone.0035885","article-title":"The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway","volume":"7","author":"Talos","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.seizure.2022.03.003_bib0014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13023-020-01396-7","article-title":"Juvenile xanthogranuloma as a new type of skin lesions in tuberous sclerosis complex","volume":"15","author":"Lu","year":"2020","journal-title":"Orphanet journal of rare diseases"},{"issue":"4","key":"10.1016\/j.seizure.2022.03.003_bib0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"International tuberous sclerosis complex consensus group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2022.03.003_bib0016","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/cge.12920","article-title":"Phenotypic and genotypic characterization of Chinese children diagnosed with tuberous sclerosis complex","volume":"91","author":"Yang","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.seizure.2022.03.003_bib0017","first-page":"1","article-title":"TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study","author":"Og\u00f3rek","year":"2020","journal-title":"Genetics Med"},{"key":"10.1016\/j.seizure.2022.03.003_bib0018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2016.11.010","article-title":"Outcome of childhood-onset epilepsy from adolescence to adulthood: transition issues","volume":"69","author":"Nabbout","year":"2017","journal-title":"Epilepsy Behavior"},{"key":"10.1016\/j.seizure.2022.03.003_bib0019","doi-asserted-by":"crossref","first-page":"B93","DOI":"10.1016\/S0149-2918(00)89026-8","article-title":"Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations","volume":"22","author":"Meier-Kriesche","year":"2000","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.seizure.2022.03.003_bib0020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1600-6143.2004.00411.x","article-title":"Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients","volume":"4","author":"Schubert","year":"2004","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.seizure.2022.03.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002233","article-title":"Pharmacokinetics of sirolimus-eluting stents implanted in the neonatal arterial duct","volume":"8","author":"Lee","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.seizure.2022.03.003_bib0022","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/FTD.0000000000000130","article-title":"Age-dependent changes in sirolimus metabolite formation in patients with neurofibromatosis type 1","volume":"37","author":"Emoto","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.seizure.2022.03.003_bib0023","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/epi.13671","article-title":"Instruction manual for the ILAE 2017 operational classification of seizure types","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2022.03.003_bib0024","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/epi.16379","article-title":"Scalp EEG spikes predict impending epilepsy in TSC infants: a longitudinal observational study","volume":"60","author":"Wu","year":"2019","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2022.03.003_bib0025","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.03.021","article-title":"A pulse rapamycin therapy for infantile spasms and associated cognitive decline","volume":"43","author":"Raffo","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.seizure.2022.03.003_bib0026","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.eplepsyres.2014.11.006","article-title":"Focal seizures versus epileptic spasms in children with focal cortical dysplasia and epilepsy onset in the first year","volume":"109","author":"Serino","year":"2015","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.seizure.2022.03.003_bib0027","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/WNF.0b013e3180986d43","article-title":"Mix E. Topiramate study group. Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms","volume":"31","author":"Zou","year":"2008","journal-title":"Clin Neuropharmacol"},{"issue":"10","key":"10.1016\/j.seizure.2022.03.003_bib0028","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.0000000000003077","article-title":"Sirolimus for epilepsy in children with tuberous sclerosis complex: a randomized controlledtrial","volume":"87","author":"Overwater","year":"2016","journal-title":"Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:58:48Z","timestamp":1761011928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":28,"alternative-id":["S1059131122000498"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.03.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus treatment for tuberous sclerosis complex prior to epilepsy: Evidence from a registry-based real-world study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}